Table 1 Patient characteristics in NYU study patients
From: Is there an androgen level threshold for aneuploidy risk in infertile women?
n | Mean | SD or 95% CI | |
|---|---|---|---|
Age (years) | 84 | 40.30 | 2.44 |
Day-2 FSH (IU/mL) | 84 | 6.64 | 2.37 |
Day-2 E2 (pg/mL) | 84 | 43.10* | 38.82 - 47.77* |
AMH (ng/mL) | 69 | 1.77* | 1.47 - 2.13* |
Total gonanadtropins (IU) | 83 | 4,098 | 1380 |
FSH (IU) | 83 | 2,646 | 1138 |
HMG (IU) | 83 | 1,451 | 889 |
Days to hCG trigger | 83 | 9.55 | 1.59 |
E2 on day of trigger (pg/mL) | 83 | 2282* | 2066 - 2522* |
Number of oocytes | 84 | 13.35* | 11.97 - 14.88* |
Number of MII oocytes | 84 | 11.85 | 6.13 |
2PN oocytes | 84 | 7.76* | 6.84 - 8.80* |
DHEA (ng/dL) | 84 | 294.7* | 257.5 – 337.4* |
Androstenedione (ng/dL) | 84 | 60.1* | 55.8 – 64.6* |
Total testosterone (ng/dL) | 84 | 16.7* | 15.4 – 18.1* |
Number of euploid embryos | 84 | 1.51 | 1.81 |
Number of aneuploid embryos | 84 | 3.62 | 2.93 |
Embryos with no diagnosis | 84 | 0.31 | 1.01 |
Ploidy Index | 84 | 0.29 | 0.29 |